Screener
MEI Pharma LITS Q1 2026 earnings
Reported May 13, 2026 · Before market open
EPS-$0.66Beat by $2.46
Revenue estimate$5.4M
EPS estimate-$3.12
Next report
Sep 28, 2026 (in a month)Revenue estimate$5.4M
EPS estimate-$3.12
Versus estimates
Diluted EPS
Q1 2026-$0.66Beat by $2.46
Q4 2025-$0.82Q3 2025-$0.12Q2 2025-$0.40Q1 2025-$0.39Q4 2024-$0.40Beat by $1.80FAQ
- When did MEI Pharma report Q1 2026 earnings?
- MEI Pharma (LITS) reported Q1 2026 earnings on May 13, 2026 before market open.
- What were MEI Pharma's Q1 2026 revenue and EPS?
- MEI Pharma reported eps of $-0.66 for Q1 2026.
- Did MEI Pharma beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-3.12 by $2.46.
- How did MEI Pharma's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 69.2% from $-0.39.
- Where can I find MEI Pharma's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-220697) and the 10-Q periodic report (0001193125-26-220687) directly on SEC EDGAR. The filing index links above go to sec.gov.
